Stefan K Bohlander Selected Research

Stefan K Bohlander Research Topics

Disease

28	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2020 - 01/2006
21	Leukemia 01/2022 - 01/2004
16	Neoplasms (Cancer) 01/2019 - 12/2007
4	Hematologic Neoplasms (Hematological Malignancy) 10/2020 - 12/2007
3	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 02/2015 - 11/2002
3	Genetic Translocation (Chromosomal Translocation) 01/2015 - 12/2007
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2014 - 12/2007
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 08/2013 - 07/2011
2	Hypoxia (Hypoxemia) 01/2019 - 01/2018
2	Lymphoma (Lymphomas) 10/2016 - 12/2008
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2010 - 11/2005
2	Chromosomal Instability (Chromosome Stability) 12/2010 - 07/2009
1	B-Cell Lymphoma (Lymphoma, B Cell) 10/2020
1	Migraine Disorders (Migraine) 12/2019
1	Disease Progression 01/2018
1	Squamous Cell Carcinoma of Head and Neck 01/2018
1	Pathologic Complete Response 01/2018
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Carcinogenesis 01/2016
1	Aneuploidy (Aneuploid) 01/2016
1	Residual Neoplasm 08/2014
1	Type V Osteogenesis Imperfecta 08/2012
1	Trisomy (Trisomies) 07/2011
1	Blast Crisis (Blast Phase) 12/2010
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 04/2009
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2006

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 10/2016 - 07/2004
6	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 07/2009
6	Transcription Factors (Transcription Factor)IBA 03/2013 - 06/2005
4	Phosphotransferases (Kinase)IBA 12/2014 - 02/2006
3	Core Binding Factors (Core-Binding Factor)IBA 01/2020 - 04/2009
3	MicroRNAs (MicroRNA)IBA 01/2016 - 12/2007
3	CCAAT-Enhancer-Binding Protein-alphaIBA 12/2010 - 02/2006
2	Cytarabine (Cytosar-U)FDA LinkGeneric 10/2020 - 12/2018
2	Oxygen (Dioxygen)IBA 01/2019 - 01/2018
2	ProdrugsIBA 01/2019 - 01/2018
2	TH 302IBA 01/2019 - 01/2018
2	RNA (Ribonucleic Acid)IBA 01/2019 - 01/2019
2	Histones (Histone)IBA 05/2015 - 12/2010
1	Opioid Receptors (Opioid Receptor)IBA 01/2022
1	venetoclaxIBA 10/2020
1	RNA Splicing FactorsIBA 10/2020
1	HomoharringtonineIBA 01/2020
1	Calcitonin Receptors (Calcitonin Receptor)IBA 12/2019
1	Neuropeptide Receptors (Neuropeptide Receptor)IBA 12/2019
1	GTP-Binding Proteins (G-Protein)IBA 12/2019
1	Oxidoreductases (Dehydrogenase)IBA 01/2019
1	Polycomb Repressive Complex 1IBA 01/2019
1	Small Interfering RNA (siRNA)IBA 01/2019
1	Mitoxantrone (Novantrone)FDA LinkGeneric 12/2018
1	CCAAT-Enhancer-Binding ProteinsIBA 10/2018
1	Mechlorethamine (Nitrogen Mustard)FDA Link 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	A-Form DNA (A-DNA)IBA 01/2018
1	Complement System Proteins (Complement)IBA 11/2016
1	Imatinib Mesylate (Gleevec)FDA Link 01/2016
1	Poly(amidoamine)IBA 01/2016
1	NucleotidesIBA 01/2016
1	flt3 ligand protein (flt3 ligand)IBA 01/2016
1	Glutamic Acid (Glutamate)FDA Link 09/2015
1	TransferasesIBA 05/2015
1	Histone MethyltransferasesIBA 05/2015
1	Janus Kinase InhibitorsIBA 02/2015
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 02/2015
1	OTS167IBA 12/2014
1	Long Noncoding RNAIBA 10/2014
1	Messenger RNA (mRNA)IBA 03/2014
1	PR-104AIBA 03/2014
1	SN 34037IBA 03/2014
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2014
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2014
1	Biological ProductsIBA 08/2013
1	Rituximab (Mabthera)FDA Link 05/2013
1	MitogensIBA 05/2013
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 12/2012
1	Collagen Type I (Type I Collagen)IBA 08/2012
1	alpha2 Subunit Collagen Type IIBA 08/2012
1	Initiator Codon (Start Codon)IBA 08/2012
1	rho GTPase-activating proteinIBA 07/2011
1	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 07/2011
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2010
1	Tyrosine (L-Tyrosine)FDA Link 12/2010
1	AnthracyclinesIBA 11/2009
1	OligonucleotidesIBA 10/2009
1	Complementary DNA (cDNA)IBA 04/2009
1	AntibodiesIBA 11/2006
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 11/2006
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 09/2006
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2006
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 02/2006
1	CytokinesIBA 11/2002

Therapy/Procedure

14	Therapeutics 01/2020 - 08/2005
2	Drug Therapy (Chemotherapy) 10/2020 - 11/2009
2	Transplantation 08/2005 - 01/2004
1	Stem Cell Transplantation 12/2018
1	Radiotherapy 01/2018
1	Induction Chemotherapy 01/2018